Addition of muramyl tripeptide to chemotherapy for patients with newly diagnosed metastatic osteosarcoma

Abstract

When the metastatic cohort was considered in isolation, the addition of liposomal MTP-PE to chemotherapy did not achieve a statistically significant improvement in outcome. However, the pattern of outcome is similar to the pattern in nonmetastatic patients.